Detailed Information
Cited 0 time in 
Cited 0 time in 
Cited 0 time in
Metadata Downloads
Efficacy and Safety of a Novel Subcutaneous Formulation of CT- P13 over the 1- year Treatment Period and After Switching from Intravenous CT- P13 in Patients with Active Rheumatoid Arthritis: Results from Part 2 of Phase I/III Randomized Controlled Trial
Full metadata record
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | 유대현 | - |
| dc.date.accessioned | 2021-08-02T10:32:17Z | - |
| dc.date.available | 2021-08-02T10:32:17Z | - |
| dc.date.issued | 2019-11-10 | - |
| dc.identifier.uri | https://scholarworks.bwise.kr/hanyang/handle/2021.sw.hanyang/12128 | - |
| dc.title | Efficacy and Safety of a Novel Subcutaneous Formulation of CT- P13 over the 1- year Treatment Period and After Switching from Intravenous CT- P13 in Patients with Active Rheumatoid Arthritis: Results from Part 2 of Phase I/III Randomized Controlled Trial | - |
| dc.type | Conference | - |
| dc.citation.conferenceName | ACR 2019 | - |
| dc.citation.conferencePlace | Atlanta, USA | - |
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - 서울 의과대학 > 서울 내과학교실 > 2. Conference Papers
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.